Clinical Trial Update: Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on the immune effects of dexmedetomidine in patients undergoing spinal fusion, with trials in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Spinal Disorders
• Spondylolisthesis
• Spondylolysis

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Sarah Network of Rehabilitation Hospitals | Conditions: Spine; Arthrosis, Spondylolysis | Phase 2, Phase 3 | Status: UNKNOWN